Latest Ratios: P/E Ratio 43.5x · EV/EBITDA 28.6x · ROE 19.1%. (2019–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.8B | $4.5B | $4.6B | $1.6B | $852M | $1.3B | $2.0B | — |
| Enterprise Value | $2.7B | $4.4B | $4.4B | $1.5B | $780M | $1.1B | $1.8B | — |
| P/E Ratio → | 43.53 | 58.16 | — | — | 7.39 | 18.23 | — | — |
| P/S Ratio | 5.18 | 9.47 | 11.50 | 5.07 | 3.15 | 5.26 | 10.11 | — |
| P/B Ratio | 5.76 | 9.30 | 13.73 | 48.13 | 11.53 | — | 30.89 | — |
| P/FCF | 17.24 | 28.93 | 37.96 | 17.49 | 74.13 | 46.37 | 32.67 | — |
| P/OCF | 16.48 | 26.67 | 34.91 | 16.14 | 41.40 | 35.94 | 29.63 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 9.26 | 11.05 | 4.53 | 2.88 | 4.67 | 9.45 | — |
| EV / EBITDA | 28.65 | 56.21 | 65.68 | 34.02 | 76.15 | 55.19 | 122.02 | — |
| EV / EBIT | 40.34 | 48.29 | — | — | 6.45 | 13.94 | 161.64 | — |
| EV / FCF | — | 28.28 | 36.48 | 15.63 | 67.84 | 41.14 | 30.54 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.2% | 84.2% | 84.4% | 83.6% | 81.3% | 82.7% | 80.6% | 79.2% |
| Operating Margin | 14.0% | 14.0% | 14.2% | 10.2% | 0.4% | 5.6% | 4.7% | -0.9% |
| Net Profit Margin | 16.5% | 16.5% | -70.5% | -24.9% | 44.6% | 29.0% | 3.0% | -1.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | 19.1% | 19.1% | -152.9% | -150.1% | 46642.9% | — | 9.4% | -3.2% |
| ROA | 9.6% | 9.6% | -46.3% | -17.3% | 32.5% | 20.3% | 1.8% | -0.7% |
| ROIC | 18.5% | 18.5% | 603.1% | — | 49.7% | — | — | — |
| ROCE | 13.8% | 13.8% | 16.9% | 14.0% | 0.6% | 7.7% | 4.8% | -0.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.05 | 0.03 | 0.41 | 0.21 | — | — | — |
| Debt / EBITDA | 0.29 | 0.29 | 0.16 | 0.33 | 1.50 | — | — | — |
| Net Debt / Equity | — | -0.21 | -0.54 | -5.13 | -0.98 | — | -2.02 | -1.30 |
| Net Debt / EBITDA | -1.30 | -1.30 | -2.68 | -4.06 | -7.06 | -7.01 | -8.53 | -29.91 |
| Debt / FCF | — | -0.65 | -1.49 | -1.86 | -6.29 | -5.22 | -2.13 | -7.71 |
| Interest Coverage | — | — | -0.79 | — | 811.47 | 538.94 | 8.01 | 4.39 |
Net cash position: cash ($124M) exceeds total debt ($23M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.56 | 1.56 | 1.92 | 1.66 | 1.42 | 1.46 | 2.03 | 2.64 |
| Quick Ratio | 1.54 | 1.54 | 1.89 | 1.62 | 1.38 | 1.43 | 2.00 | 2.60 |
| Cash Ratio | 1.18 | 1.18 | 1.51 | 1.19 | 0.88 | 0.97 | 1.49 | 2.02 |
| Asset Turnover | — | 0.51 | 0.58 | 0.61 | 0.67 | 0.72 | 0.53 | 0.61 |
| Inventory Turnover | 9.89 | 9.89 | 7.00 | 5.36 | 4.99 | 6.54 | 7.97 | 9.05 |
| Days Sales Outstanding | — | 80.55 | 74.93 | 86.75 | 106.22 | 100.06 | 124.20 | 93.95 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | 7.7% | 0.5% | — |
| Payout Ratio | — | — | — | — | — | 140.1% | 173.0% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.3% | 1.7% | — | — | 13.5% | 5.5% | — | — |
| FCF Yield | 5.8% | 3.5% | 2.6% | 5.7% | 1.3% | 2.2% | 3.1% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 7.7% | 0.5% | — |
| Shares Outstanding | — | $250M | $209M | $190M | $195M | $162M | $187M | $187M |
Includes 30+ ratios · 7 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CLBT stock.
Cellebrite DI Ltd.'s current P/E ratio is 43.5x. The historical average is 27.9x. This places it at the 67th percentile of its historical range.
Cellebrite DI Ltd.'s current EV/EBITDA is 28.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 57.4x.
Cellebrite DI Ltd.'s return on equity (ROE) is 19.1%. The historical average is -55.5%.
Based on historical data, Cellebrite DI Ltd. is trading at a P/E of 43.5x. This is at the 67th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Cellebrite DI Ltd. has 84.2% gross margin and 14.0% operating margin. Operating margin between 10-20% is typical for established companies.
Cellebrite DI Ltd.'s Debt/EBITDA ratio is 0.3x, indicating low leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Volatile quarterly cash conversion and earnings quality
Premium Multiples Priced for Sustained Growth
Based on reported figures, CLBT trades at 44.97x trailing earnings and 29.63x trailing EBITDA, a premium to most listed peers that suggests investors are paying for durable double-digit growth rather than current earnings power.
The gap between trailing P/E of 44.97x and forward P/E of 41.79x implies modest expected earnings expansion, which is less than the implied growth typically required to justify such a multiple. The compression from 29.63x trailing EV/EBITDA to 13.72x forward suggests the forward EBITDA estimate is substantially higher, a discrepancy warranting investigation into the underlying assumptions. Relative to the peer group, where SPSC and OSPN trade near 35x and 12.5x earnings respectively, CLBT's multiple appears to embed a scarcity premium tied to its proprietary forensic moat.
Gross Margin Strength Masked by Reinvestment
As reported in quarterly income statements, CLBT's gross margin has held between 80% and 86% across ten quarters, while operating margin has fluctuated from roughly 6% to 18%, indicating that reinvestment rather than unit economics drives most earnings variability.
The consistency of gross margin suggests pricing power and a software-weighted revenue mix, which is a genuine structural strength. However, the wide swing in operating margin points to substantial discretionary spending in R&D and sales that may be deliberately variable. Investors should monitor whether operating margin can sustain levels above 15% once reinvestment normalizes, since current earnings appear more dependent on expense timing than on scalable operating leverage.
Low Returns Reflect Heavy Equity Base
Based on reported figures, CLBT's ROE of 4.8% and ROIC of 5.0% in 2026Q3 remain well below the peer average, suggesting the equity base has grown faster than the earnings it generates.
The expansion of total assets from roughly $557M to $1.1B, combined with a goodwill step-up, has enlarged the capital base without a proportional rise in returns. This pattern may indicate that acquired goodwill is diluting the return metrics even as organic operations improve. Compared with OSPN's 25.4% ROE and 21.7% ROIC, CLBT's returns appear structurally lower, warranting attention to whether recent acquisitions will eventually earn their cost of capital.
Ample Liquidity With Deferred Revenue Ambiguity
According to reported quarterly balance sheets, CLBT's current ratio has held between 1.53 and 2.11, with cash of $223.1M in 2026Q3, indicating a comfortable short-term liquidity buffer relative to near-term obligations.
The current ratio consistently above 1.5 suggests the company can meet short-term obligations without relying on external financing. However, the reported deferred revenue balance reading zero in 2026Q3 after $327.8M in 2025Q4 is a data gap that prevents confident assessment of forward billings. Under severe stress, liquidity would depend heavily on cash preservation, since inventory dependence is low but receivables timing drives significant quarterly swings.
Quality of Earnings Warrants Closer Scrutiny
Based on reported figures, CLBT's 2026Q3 net margin of 17.9% slightly exceeds its operating margin of 18.0% only marginally, while stock-based compensation of $15.4M may be flattering cash flow relative to economic earnings.
The most commonly misapplied ratio for this business model is the trailing P/E, which can understate the economic cost of stock-based compensation that reached $15.4M in a single quarter. A more appropriate lens may be EV/FCF adjusted for SBC, since reported free cash flow margins swing between roughly 11% and 61% and are heavily influenced by working capital timing. Investors should monitor whether the gap between reported earnings and cash generation narrows as the subscription base matures.